NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 348 filers reported holding NEKTAR THERAPEUTICS in Q4 2018. The put-call ratio across all filers is 0.59 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $730,000 | +224.4% | 40,102 | +498.3% | 0.04% | +184.6% |
Q1 2019 | $225,000 | -90.8% | 6,703 | -91.0% | 0.01% | -91.7% |
Q4 2018 | $2,446,000 | +71.9% | 74,416 | +218.8% | 0.16% | +141.5% |
Q3 2018 | $1,423,000 | -85.0% | 23,346 | -88.0% | 0.06% | -83.2% |
Q2 2018 | $9,514,000 | +3347.1% | 194,846 | +766.0% | 0.39% | +2318.8% |
Q4 2016 | $276,000 | -23.8% | 22,500 | -14.7% | 0.02% | 0.0% |
Q1 2016 | $362,000 | -71.7% | 26,376 | -75.1% | 0.02% | -76.5% |
Q1 2014 | $1,281,000 | -49.7% | 105,724 | -52.9% | 0.07% | -49.6% |
Q4 2013 | $2,546,000 | – | 224,320 | – | 0.14% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ally Bridge Group (NY) LLC | 432,952 | $1,385,000 | 0.91% |
GREAT POINT PARTNERS LLC | 447,820 | $1,433,000 | 0.34% |
Birchview Capital, LP | 128,000 | $410,000 | 0.29% |
Edgestream Partners, L.P. | 1,047,636 | $3,352,000 | 0.26% |
Rhenman & Partners Asset Management AB | 550,000 | $2,068,000 | 0.22% |
CM Management, LLC | 50,000 | $160,000 | 0.18% |
TANG CAPITAL MANAGEMENT LLC | 430,037 | $1,376,000 | 0.17% |
PDT Partners, LLC | 307,953 | $985,000 | 0.15% |
Virtus ETF Advisers LLC | 72,018 | $230,000 | 0.09% |
ALGERT GLOBAL LLC | 476,412 | $1,525,000 | 0.09% |